![Prostate Cancer Foundation](data:image/svg+xml;utf8,<svg xmlns="http://www.w3.org/2000/svg" width="100%" height="100%"><rect width="100%" height="100%"><animate attributeName="fill" values="rgba(153,153,153,0.5);rgba(153,153,153,0.1);rgba(153,153,153,0.5)" dur="2s" repeatCount="indefinite" /></rect></svg>)
![Prostate Cancer Foundation](data:image/svg+xml;utf8,<svg xmlns="http://www.w3.org/2000/svg" width="250" height="148"><rect width="100%" height="100%"><animate attributeName="fill" values="rgba(153,153,153,0.5);rgba(153,153,153,0.1);rgba(153,153,153,0.5)" dur="2s" repeatCount="indefinite" /></rect></svg>)
09/09/2022
Improving Erectile Function, Part 1: What You Can Do Before Surgery
If you’ve been diagnosed with localized prostate cancer and are considering having surgery (radical prostatectomy), you may be concerned about potential side effects, including loss of erectile function. About 40% of men lose some erectile function after surgery. This can have a major impact on quality of life for both. Read More
09/01/2022
Should You Run or Walk?
This month’s challenge is all about lacing up your sneakers and hitting the pavement, trail, or treadmill. It all counts: walking, hiking, trail-running, race-walking, even pool running. Is it better to run or walk? The decision is personal. Let’s consider a few factors that might help you choose. Which is. Read More
08/31/2022
More Evidence For Benefits of Radiation Therapy in Metastatic Prostate Cancer
In the U.S., between 2010-2019, nearly 7% of patients diagnosed with prostate cancer had metastatic disease at diagnosis. In 2022, this could translate into more than 18,000 people. Multiple treatment options exist, including combinations of standard androgen deprivation therapy (ADT), novel hormonal therapies, and docetaxel. Since 2019, radiation therapy (RT). Read More
08/31/2022
From the White House: A Proclamation on National Prostate Cancer Awareness Month, 2022
Repost from: https://www.whitehouse.gov/briefing-room/presidential-actions/2022/08/31/a-proclamation-on-national-prostate-cancer-awareness-month-2022/ During National Prostate Cancer Awareness Month, we recommit ourselves to taking on a cancer that will affect over 260,000 people in America this year alone. It is for those we have lost, those who continue to fight, and those who will undergo this battle in the future that. Read More
08/24/2022
PACT Act Expands Health Care for Veterans
Earlier this month, President Biden signed into law S. 3373, “The Sergeant First Class Heath Robinson Honoring Our Promises to Address Comprehensive Toxics (PACT) Act of 2022.” Prostate Cancer Foundation President and CEO Dr. Charles J. Ryan had the privilege of representing PCF at the White House signing ceremony. The. Read More
08/15/2022
From the Prostate Cancer Research Desk: Benefits of COVID-19 Vaccines, PSA Screening
In this roundup of recent prostate cancer research, data from the U.S. Veterans Health Administration yields insights into the benefits of COVID-19 vaccination and of PSA screening. COVID-19 vaccination protects patients with cancer against infection and death In case you needed another reason to get a COVID-19 vaccine or booster,. Read More
Easy Fish Tacos
Easy Fish Tacos Adapted from delish.com Prep time: 20 minutes Cook time: 15 minutes Serves: 4 Ingredients: Fish 3 tbsp. extra-virgin olive oil Juice of 1 lime 2 tsp. chili powder 1 tsp. paprika 1/2 tsp. ground cumin 1/2 tsp. cayenne pepper 1 1/2 lb. cod (or other flaky white. Read More
08/15/2022
Easy Fish Tacos
As the heat of summer continues, it’s a good time to leave the oven off and opt for a quick, healthy, stovetop-only dinner. This fish taco recipe allows you to make the fresh corn-and-cabbage slaw while the fish marinates in a simple, clean mix of olive oil, lime juice, and. Read More
08/05/2022
Breaking News: FDA Approves Darolutamide for Metastatic Hormone-Sensitive Prostate Cancer
Today, the FDA approved darolutamide in combination with docetaxel chemotherapy for patients with metastatic hormone-sensitive prostate cancer (mHSPC). This means that patients with mHSPC (prostate cancer that has spread beyond the prostate and is responsive to hormone therapy, or who have not yet received hormone therapy) have an additional treatment. Read More
07/26/2022
Researchers Identify a New Subtype of Advanced Prostate Cancer
A PCF-funded study published in the prestigious journal Science has identified a new subtype of castration-resistant prostate cancer (CRPC). Understanding how genes and proteins “drive” this particular type of cancer may lead to new treatments. In the early stages, prostate cancer cells are driven by androgens (e.g., testosterone), which naturally. Read More